Chris Francis, See Remarks at Wave Life Sciences Ltd. (WVE), sold 591,505 shares at $14.08 ($8.6M) on 2025-12-08, disclosed to the SEC on 2025-12-10.
Scheduled sale ($8.6M) by See Remarks under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.08 | 22,500 | $317K | 3.7% |
| 2 | $14.08 | 37,500 | $528K | 6.2% |
| 3 | $14.20 | 122,349 | $1.7M | 20.3% |
| 4 | $14.20 | 122,349 | $1.7M | 20.3% |
| 5 | $14.50 | 28,125 | $408K | 4.8% |
| 6 | $14.50 | 45,882 |
| $665K |
| 7.8% |
| 7 | $14.50 | 28,125 | $408K | 4.8% |
| 8 | $14.56 | 107,400 | $1.6M | 18.2% |
| 9 | $15.00 | 17,900 | $269K | 3.1% |
| 10 | $15.00 | 9,375 | $141K | 1.6% |
| 11 | $16.00 | 50,000 | $800K | 9.3% |
| Total | $14.49 avg | 591,505 | $8.6M | 100% |
| Filing → |
| WVE | SELL | 2026-01-06 | $150K | — | Filing → |
| WVE | SELL | 2024-11-13 | $576K | — | Filing → |
| WVE | SELL | 2024-10-18 | $3.8M | — | Filing → |